A commentary on 'Comparison of efficacy and safety between neoadjuvant chemotherapy and neoadjuvant immune checkpoint inhibitors combined with chemotherapy for locally advanced esophageal squamous cell carcinoma: a systematic review and meta-analysis'

被引：0
|
作者：
Qiao, Letian [1 ]
Liu, Yuan [1 ]
Ge, Dahe [2 ,4 ]
Jiang, Shuang [3 ]
机构：
[1] First Peoples Hosp Shangqiu, Dept Pharm, Henan, Peoples R China
[2] First Peoples Hosp Shangqiu, Dept Gastroenterol, Henan, Peoples R China
[3] First Peoples Hosp Shangqiu, Dept Emergency, Intens Care Unit, Henan, Peoples R China
[4] First Peoples Hosp Shangqiu, Henan 476100, Peoples R China
来源：
INTERNATIONAL JOURNAL OF SURGERY | 2024年 / 110卷 / 05期
关键词：
D O I：
10.1097/JS9.0000000000001211
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：3118 / 3119
页数：2
相关论文
共 50 条
  • [41] Meta-analysis of the efficacy of neoadjuvant chemotherapy for locally advanced cervical cancer
    Wang, Daying
    Fang, Xiuli
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2024, 297 : 202 - 208
  • [42] Neoadjuvant immune checkpoint inhibitor in combination with chemotherapy or chemoradiotherapy in resectable esophageal cancer: A systematic review and meta-analysis
    Wang, He
    Li, Sihan
    Liu, Tingting
    Chen, Jun
    Dang, Jun
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [43] Neoadjuvant chemotherapy in locally advanced colon cancer: A systematic review with proportional meta-analysis
    van den Berg, K.
    van Hellemond, I. E. G.
    Willems, J. M. W. E.
    Burger, J. W. A.
    Rutten, H. J. T.
    Creemers, G. J.
    EJSO, 2025, 51 (03):
  • [44] Neoadjuvant Immune Checkpoint Inhibitors for Resectable Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
    Zhao, Mei
    Chen, Shanwen
    Li, Conggui
    Du, Yingying
    Li, Ping
    CANCERS, 2023, 15 (03)
  • [45] The efficacy of neoadjuvant chemotherapy as compared to upfront surgery for the management of oral squamous cell carcinoma: a systematic review and meta-analysis
    Kende, P.
    Mathur, Y.
    Tayal, S.
    Patyal, N.
    Landge, J.
    INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2024, 53 (01) : 1 - 10
  • [46] Neoadjuvant chemoimmunotherapy for locally advanced squamous cell carcinoma of the head and neck: Systematic review and meta-analysis
    Zhu, Xiayi
    Qiu, Jie
    Zhang, Ya
    Lin, Chunni
    Wang, Xiaohui
    Shi, Xiwei
    Yang, Siya
    Wu, Qiaoyan
    Cong, Li
    PHARMACOLOGICAL RESEARCH, 2025, 212
  • [47] Comparison of neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for esophageal cancer: a meta-analysis
    Jing, Shao-wu
    Qin, Jian-jun
    Liu, Qing
    Zhai, Chang
    Wu, Ya-jing
    Cheng, Yun-jie
    Czito, Brian G.
    Wang, Jun
    FUTURE ONCOLOGY, 2019, 15 (20) : 2413 - 2422
  • [48] Efficacy and Safety of Neoadjuvant Chemoimmunotherapy in Resectable Esophageal Squamous Cell Carcinoma: A Meta-analysis
    Xu, Jinxin
    Yan, Chun
    Li, Zhe
    Cao, Yunpeng
    Duan, Hongbing
    Ke, Sunkui
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (03) : 1597 - 1613
  • [49] Efficacy and Safety of Neoadjuvant Chemoimmunotherapy in Resectable Esophageal Squamous Cell Carcinoma: A Meta-analysis
    Jinxin Xu
    Chun Yan
    Zhe Li
    Yunpeng Cao
    Hongbing Duan
    Sunkui Ke
    Annals of Surgical Oncology, 2023, 30 (3) : 1597 - 1613
  • [50] Comparison of the efficacy and safety of neoadjuvant PD-1 inhibitors plus chemotherapy vs targeted therapy plus chemotherapy in locally advanced hypopharyngeal squamous cell carcinoma
    Gao, Wen
    Feng, Lifei
    Zhao, Xinming
    Huang, Zishi
    Chen, Duoxuan
    Yin, Gaofei
    Guo, Wei
    Zhong, Qi
    Chen, Xiaohong
    Fang, Jugao
    Zhang, Yang
    Huang, Zhigang
    FRONTIERS IN IMMUNOLOGY, 2024, 15
12345